Riboscience Presents Phase 1a/b Overall Survival Data for RBS2418
Riboscience reported median overall survival of 12 months with RBS2418 monotherapy in heavily pretreated subjects; the body is truncated.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.